Trial Profile
Evaluate the Safety of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by The Company for Vaccine and Biological Production No.1 in Vietnamese Children Aged 9-24 Months
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2018
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Acronyms JECEVAX-2B
- 14 Sep 2017 Status changed from recruiting to completed.
- 04 Jul 2017 New trial record